Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
Tags:
M&A, patent cliffs, Merck, JNJ, Pfizer, GSK, Novartis, Eli Lilly, Novo Nordisk
J&J's patient assistance program suffers data breach, IBM says
Fierce Pharma
Thu, 09/7/23 - 09:43 am
Tags:
JNJ, Janssen, IBM, patient assistance programs, cybersecurity
J&J sends blood pressure drug back to Idorsia
BioPharma Dive
Wed, 09/6/23 - 11:54 am
Tags:
Idorsia, JNJ, aprocitentan, hypertension
Despite price drops, J&J gets little reprieve from TB drug saga
Medical Marketing and Media
Wed, 09/6/23 - 10:12 am
Tags:
JNJ, tuberculosis, generics, bedaquiline
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Motley Fool
Thu, 08/31/23 - 11:01 am
Tags:
Medicare, JNJ, drug pricing
Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower
Fierce Pharma
Wed, 08/30/23 - 11:29 pm
Tags:
JNJ, M&A, consumer health, Kenvue
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare, HHS, Pfizer, Bristol Myers Squibb, Eli Lilly, Boehringer Ingelheim, AstraZeneca, AbbVie, Novo Nordisk, JNJ, drug pricing
5 of the best places to work in pharma, according to employees
Pharma Voice
Tue, 08/29/23 - 11:32 am
Tags:
Glassdoor, Merck, JNJ, Pfizer, GSK, Sanofi
J&J ends R&D at Janssen's infectious disease and vaccine unit
Fierce Biotech
Wed, 08/23/23 - 05:40 pm
Tags:
JNJ, infectious disease, vaccines, R&D
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
Tags:
patent cliff, patents, Takeda, Vyvanse, Pfizer, Eraxis, JNJ, Stelara, Merck, Isentress, Eiger Pharmaceuticals, Zokinvy, Astellas, Myrbetriq, Novartis, Entresto, Amgen, Otzela
Regeneron, J&J Win HHS Funding to Develop Next-Gen COVID Products
BioSpace
Wed, 08/23/23 - 09:54 am
Tags:
HHS, Regeneron, JNJ, COVID-19, funding
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
Tags:
earnings, Eli Lilly, JNJ, Novo Nordisk, Novartis, AstraZeneca
Behind the FDA Submission: How J&J Won a Key Approval in AF Ablation
Medical Devices and Diagnostics Industry
Tue, 08/22/23 - 09:56 am
Tags:
JNJ, Medtech, Biosense Webster, FDA, cardiac ablation
Janssen granted additional European Commission approval for bispecific antibody
Biopharma Reporter
Tue, 08/22/23 - 09:54 am
Tags:
Janssen, JNJ, bispecific antibodies, Europe, relapsed or refractory multiple myeloma
Johnson & Johnson to keep a 9.5% stake in consumer health spinoff Kenvue stake after exchange offer
Fierce Pharma
Mon, 08/21/23 - 06:55 pm
Tags:
JNJ, consumer health, spinoff, Kenvue
J&J’s Abiomed updates labeling for certain Impella heart pumps in Class I safety event
Fierce Biotech
Sun, 08/20/23 - 05:15 pm
Tags:
Medtech, JNJ, Abiomed, Impella, product recalls, device recalls
J&J joins PARP rivals with narrow FDA clearance in prostate cancer
BioPharma Dive
Mon, 08/14/23 - 10:18 am
Tags:
JNJ, Akeega, BRCA-mutated prostate cancer, PARP inhibitors, FDA
J&J bags first FDA approval for a GPRC5D drug
Pharmaphorum
Thu, 08/10/23 - 09:52 am
Tags:
JNJ, FDA, GPRC5D, Talvey, relapsed or refractory multiple myeloma
Johnson & Johnson's Talc Problems Aren't Going Away
Motley Fool
Wed, 08/9/23 - 10:05 am
Tags:
JNJ, talc, legal
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Fierce Pharma
Mon, 08/7/23 - 10:52 am
Tags:
JNJ, Stelara, patents, legal, Formycon, Fresenius Kabi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.